CD226 and hepatocellular carcinoma: They can inhibit HCC through signaling pathways, such as with the activation of NKG2D/DNAM-1, yet they can also upregulate PD-1 expression to suppress their own cytotoxic function, thus promoting tumor escape (59, 60).